These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 34656765)

  • 1. MicroRNA targets and biomarker validation for diabetes-associated cardiac fibrosis.
    Jin ZQ
    Pharmacol Res; 2021 Dec; 174():105941. PubMed ID: 34656765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-21-3p triggers cardiac fibroblasts pyroptosis in diabetic cardiac fibrosis via inhibiting androgen receptor.
    Shi P; Zhao XD; Shi KH; Ding XS; Tao H
    Exp Cell Res; 2021 Feb; 399(2):112464. PubMed ID: 33385416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy.
    Fang L; Ellims AH; Moore XL; White DA; Taylor AJ; Chin-Dusting J; Dart AM
    J Transl Med; 2015 Sep; 13():314. PubMed ID: 26404540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosomal microRNAs miR-30d-5p and miR-126a-5p Are Associated with Heart Failure with Preserved Ejection Fraction in STZ-Induced Type 1 Diabetic Rats.
    Huang JP; Chang CC; Kuo CY; Huang KJ; Sokal EM; Chen KH; Hung LM
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-18a-5p inhibits endothelial-mesenchymal transition and cardiac fibrosis through the Notch2 pathway.
    Geng H; Guan J
    Biochem Biophys Res Commun; 2017 Sep; 491(2):329-336. PubMed ID: 28733035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression profiles and bioinformatic analysis of microRNAs in myocardium of diabetic cardiomyopathy mice.
    Wang T; Yuan L; Chen Y; Wang J; Li N; Zhou H
    Genes Genomics; 2023 Aug; 45(8):1003-1011. PubMed ID: 37253907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-30a-5p inhibits the proliferation and collagen formation of cardiac fibroblasts in diabetic cardiomyopathy.
    Yang XX; Zhao ZY
    Can J Physiol Pharmacol; 2022 Feb; 100(2):167-175. PubMed ID: 35025607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of microRNA-150-5p alleviates cardiac inflammation and fibrosis via targeting Smad7 in high glucose-treated cardiac fibroblasts.
    Che H; Wang Y; Li Y; Lv J; Li H; Liu Y; Dong R; Sun Y; Xu X; Zhao J; Wang L
    J Cell Physiol; 2020 Nov; 235(11):7769-7779. PubMed ID: 31710102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microarray profiling analysis identifies the mechanism of miR-200b-3p/mRNA-CD36 affecting diabetic cardiomyopathy via peroxisome proliferator activated receptor-γ signaling pathway.
    Xu L; Chen W; Ma M; Chen A; Tang C; Zhang C; Cai L
    J Cell Biochem; 2019 Apr; 120(4):5193-5206. PubMed ID: 30506990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between downregulation of miRNAs and increase of oxidative stress in the development of diabetic cardiac dysfunction: junctin as a target protein of miR-1.
    Yildirim SS; Akman D; Catalucci D; Turan B
    Cell Biochem Biophys; 2013; 67(3):1397-408. PubMed ID: 23723006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA DCRF regulates cardiomyocyte autophagy by targeting miR-551b-5p in diabetic cardiomyopathy.
    Feng Y; Xu W; Zhang W; Wang W; Liu T; Zhou X
    Theranostics; 2019; 9(15):4558-4566. PubMed ID: 31285779
    [No Abstract]   [Full Text] [Related]  

  • 12. CircRNA_000203 enhances the expression of fibrosis-associated genes by derepressing targets of miR-26b-5p, Col1a2 and CTGF, in cardiac fibroblasts.
    Tang CM; Zhang M; Huang L; Hu ZQ; Zhu JN; Xiao Z; Zhang Z; Lin QX; Zheng XL; -Yang M; Wu SL; Cheng JD; Shan ZX
    Sci Rep; 2017 Jan; 7():40342. PubMed ID: 28079129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-410-5p promotes the development of diabetic cardiomyopathy by suppressing PIM1-induced anti-apoptosis.
    Xia X; Liang Y; Zheng W; Lin D; Sun S
    Mol Cell Probes; 2020 Aug; 52():101558. PubMed ID: 32145290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating microRNAs in diabetic cardiomyopathy as tools for early detection and therapeutics.
    Mathur P; Rani V
    Mol Cell Biochem; 2023 Feb; 478(2):229-240. PubMed ID: 35779226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-20a-5p overexpression prevented diabetic cardiomyopathy via inhibition of cardiomyocyte apoptosis, hypertrophy, fibrosis and JNK/NF-κB signalling pathway.
    Liu X; Guo B; Zhang W; Ma B; Li Y
    J Biochem; 2021 Oct; 170(3):349-362. PubMed ID: 33837411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring miRNA-mRNA regulatory network in cardiac pathology in Na
    Xue J; Zhou D; Poulsen O; Hartley I; Imamura T; Xie EX; Haddad GG
    Physiol Genomics; 2018 Oct; 50(10):846-861. PubMed ID: 30029588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating cardiac MicroRNAs safeguard against dilated cardiomyopathy.
    Cheng X; Jian D; Xing J; Liu C; Liu Y; Cui C; Li Z; Wang S; Li R; Ma X; Wang Y; Gu X; Ge Z; Tang H; Liu L
    Clin Transl Med; 2023 May; 13(5):e1258. PubMed ID: 37138538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-30d regulates cardiomyocyte pyroptosis by directly targeting foxo3a in diabetic cardiomyopathy.
    Li X; Du N; Zhang Q; Li J; Chen X; Liu X; Hu Y; Qin W; Shen N; Xu C; Fang Z; Wei Y; Wang R; Du Z; Zhang Y; Lu Y
    Cell Death Dis; 2014 Oct; 5(10):e1479. PubMed ID: 25341033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA profiling unveils hyperglycaemic memory in the diabetic heart.
    Costantino S; Paneni F; Lüscher TF; Cosentino F
    Eur Heart J; 2016 Feb; 37(6):572-6. PubMed ID: 26553540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential molecular mechanism underlying cardiac fibrosis in diabetes mellitus: a narrative review.
    Ridwan M; Dimiati H; Syukri M; Lesmana R
    Egypt Heart J; 2023 Jun; 75(1):46. PubMed ID: 37306727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.